Pharmacotherapy of the Ion Transport Defect in Cystic Fibrosis: Role of Purinergic Receptor Agonists and Other Potential Therapeutics

Author： Kunzelmann K.   Mall M.  

Publisher： Adis International

ISSN： 1175-6365

Source： American Journal of Respiratory Medicine, Vol.2, Iss.4, 2003-01, pp. : 299-309

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological Approaches to Correcting the Ion Transport Defect in Cystic Fibrosis

By Roomans G.M.  

American Journal of Respiratory Medicine, Vol. 2, Iss. 5, 2003-01 ,pp. : 413-431

Adis International

Access to resources Recommend Favorite

Macrolides in Cystic Fibrosis: Is There a Role?

By Wolter J.M.   Seeney S.L.   McCormack J.G.  

American Journal of Respiratory Medicine, Vol. 1, Iss. 4, 2002-04 ,pp. : 235-241

Adis International

Access to resources Recommend Favorite

Role of Pharmacotherapy in Cardiac Ion Channelopathies

By  

Current Vascular Pharmacology, Vol. 7, Iss. 3, 2009-01 ,pp. : 358-366

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Role of Bile Acids and Nuclear Receptor Agonists in Fibrosing Cholangiopathies

By  

Digestive Diseases, Vol. 32, Iss. 5, 2014-07 ,pp. : 631-636

Karger

Access to resources Recommend Favorite

Sleep Disturbances in Cystic Fibrosis

By  

Current Respiratory Medicine Reviews, Vol. 5, Iss. 4, 2009-11 ,pp. : 230-232

Bentham Science Publishers

Access to resources Recommend Favorite